SCHEMBL6175536

SCHEMBL6175536

CC(c1ccnc(OC(=O)c2ccccc2)c1)C1(C(C)c2ccnc(OC(=O)c3ccccc3)c2)NC(=O)N(c2ccc(S(=O)(=O)C(F)(F)F)cc2)C1=O

nearest known ligand 0.37

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
IGF1R P08069 2/20 0.37
ALDH1A1 P00352 2/20 0.34
LMNA P02545 2/20 0.33
AR P10275 1/20 0.33
CYP3A4 P08684 1/20 0.33
GAA P10253 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
TRPV3 Q8NET8 4/20 0.32
KMT2A Q03164 2/20 0.32
USP2 O75604 1/20 0.32
MAPT P10636 1/20 0.32
HPGD P15428 1/20 0.32
HSD17B10 Q99714 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
DHFR P00374 1/20 0.31
PTGS2 P35354 1/20 0.31
THRB P10828 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6172376 0.88 ALDH1A1 (0.37) ALDH1A1LMNACYP3A4GAACYP2C9
SCHEMBL6171339 0.87 IGF1R (0.39) IGF1RALDH1A1LMNAARCYP3A4
SCHEMBL6174624 0.86 IGF1R (0.39) IGF1RALDH1A1LMNA
SCHEMBL6172497 0.85 IGF1R (0.37) IGF1RALDH1A1LMNAARCYP3A4
SCHEMBL6175145 0.84 ALDH1A1 (0.40) IGF1RALDH1A1LMNACYP3A4GAA
SCHEMBL6173058 0.83 IGF1R (0.36) IGF1RALDH1A1LMNAARCYP3A4
SCHEMBL6172914 0.81 IGF1R (0.38) IGF1RLMNAARCYP3A4GAA
SCHEMBL6176124 0.81 IGF1R (0.42) IGF1RLMNAARTRPV3KMT2A
SCHEMBL6173852 0.80 IGF1R (0.37) IGF1RARTRPV3KMT2AMAPT
SCHEMBL6201343 0.80 PTGS2 (0.40) IGF1RLMNAARCYP3A4CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599464-A2 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS Aventis Pharma S.A. (FR) 2005-11-30 EP disclosed
WO-2004070050-A2 CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2004-08-19 WO disclosed